欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/0664/001
药品名称
Tiapride ratiopharm 100 mg
活性成分
tiapride hydrochloride 100.0 mg
剂型
Tablet
上市许可持有人
Ratiopharm GmbH Graf-Arco-strasse 3 D-89079 ULM Germany
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
许可日期
2005/11/29
最近更新日期
2020/03/17
药物ATC编码
N05AL03 tiapride
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Multiple (Copy) Application
TypeLevel3：
Generic [Article 10.1.(a)(iii), first paragraph]
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
Annex A Tiapride 100 mg tablets_SmPC renewal final
Date of last change:2024/09/06
Final Product Information
|
Annex B Tiapride 100 mg tablets_P renewal final
Date of last change:2024/09/06
Final Product Information
|
Annex C labelling blister renewal final
Date of last change:2024/09/06
Final Product Information
|
Annex C labelling outer renewal final
Date of last change:2024/09/06
Final Labelling
|
Tiapride 100 mg tablets_OuP_NL_H_0664_001_MR_26_07_17
Date of last change:2024/09/06
Final PL
|
Tiapride 100 mg tablets_PIL_NL_H_0664_001_26_07_17
Date of last change:2024/09/06
Final SPC
|
Tiapride 100 mg tablets_SmPC_NL_H_0664_001_26_07_17
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase